Urigen appoints director
This article was originally published in Scrip
Executive Summary
Urigen Pharmaceuticals, a speciality US company developing treatments for urological disorders and pain, has elected Dr Dan Vickery to its board of directors. Dr Vickery previously worked for Mylan Pharmaceuticals in senior business development before setting up his own consultancy business in 2005.